Refractory diabetic ketoacidosis secondary to sodium-glucose co-transporter 2 inhibitor use

被引：0

作者：

Ravishankar, Nivedha ^{[1
]}

Clayton, Samantha ^{[1
]}

机构：

[1] West Suffolk Hosp, Bury St Edmunds, Suffolk, England

来源：

ANAESTHESIA | 2024年 / 79卷

关键词：

D O I：

暂无

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

016

引用

页码：14 / 14

页数：1

共 50 条

[41] Sodium Glucose Co-Transporter 2 Inhibitor Use Post-Transplant [J].

Nickol, J. ;

Azmeen, A. ;

Stoller, D. ;

Lyden, E. ;

Zolty, R. ;

Lundgren, S. .

JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2025, 44 (04)

[42] Sodium-glucose co-transporter-2 inhibitors and the risk of perioperative euglycaemic diabetic ketoacidosis [J].

Williams, Samuel P. ;

Stevens, Jia L. ;

Rajendran, Yohinee K. .

BRITISH JOURNAL OF HOSPITAL MEDICINE, 2022, 83 (11)

[43] Practical Considerations for the Use of Sodium-Glucose Co-Transporter 2 Inhibitors in Heart Failure [J].

Honigberg, Michael C. ;

Vardeny, Orly ;

Vaduganathan, Muthiah .

CIRCULATION-HEART FAILURE, 2020, 13 (02)

[44] Sodium Glucose Co-Transporter 2 Inhibitor Use in HeartMate 3 Patients [J].

Cali, F. ;

Ladanyi, A. ;

Pinsino, A. ;

Antler, K. ;

Murphy, J. ;

Mondellini, G. M. ;

Kaku, Y. ;

Sayer, G. ;

Uriel, N. ;

Takeda, K. ;

Colombo, P. C. ;

Jennings, D. ;

Yuzefpolskaya, M. .

JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04) :S647-S647

[45] Potential Mechanisms of Sodium-Glucose Co-Transporter 2 Inhibitor-Related Cardiovascular Benefits [J].

Verma, Subodh .

AMERICAN JOURNAL OF CARDIOLOGY, 2019, 124 :S36-S44

[46] Advances in the management of diabetic kidney disease: beyond sodium-glucose co-transporter 2 inhibitors [J].

Chan, Anthony T. P. ;

Tang, Sydney C. W. .

KIDNEY RESEARCH AND CLINICAL PRACTICE, 2022, 41 (06) :682-698

[47] Potential Mechanisms of Sodium-Glucose Co-Transporter 2 Inhibitor-Related Cardiovascular Benefits [J].

Verma, Subodh .

AMERICAN JOURNAL OF MEDICINE, 2019, 132 (10) :S39-S48

[48] Medication Use Evaluation: Use of Sodium-glucose Co-transporter 2 (SGLT2) Inhibitors [J].

Diep, Thaomi ;

Brown, Stephanie .

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2025, 82 :S2371-S2371

[49] Clinical Pharmacokinetics and Pharmacodynamics of Dapagliflozin, a Selective Inhibitor of Sodium-Glucose Co-transporter Type 2 [J].

Kasichayanula, Sreeneeranj ;

Liu, Xiaoni ;

LaCreta, Frank ;

Griffen, Steven C. ;

Boulton, David W. .

CLINICAL PHARMACOKINETICS, 2014, 53 (01) :17-27

[50] Clinical Pharmacokinetics and Pharmacodynamics of Dapagliflozin, a Selective Inhibitor of Sodium-Glucose Co-transporter Type 2 [J].

Sreeneeranj Kasichayanula ;

Xiaoni Liu ;

Frank LaCreta ;

Steven C. Griffen ;

David W. Boulton .

Clinical Pharmacokinetics, 2014, 53 :17-27

← 1 2 3 4 5 →